Analysts Offer Insights on Healthcare Companies: Medtronic (NYSE: MDT) and Teladoc (NYSE: TDOC)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Medtronic (MDTResearch Report) and Teladoc (TDOCResearch Report).

Medtronic (MDT)

Credit Suisse analyst Matt Miksic reiterated a Buy rating on Medtronic today and set a price target of $117.00. The company’s shares closed last Friday at $94.24.

According to TipRanks.com, Miksic is a 5-star analyst with an average return of 10.7% and a 67.0% success rate. Miksic covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Baxter International, and Edwards Lifesciences.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Medtronic with a $112.18 average price target, representing a 17.4% upside. In a report released today, Oppenheimer also maintained a Buy rating on the stock with a $112.00 price target.

See today’s analyst top recommended stocks >>

Teladoc (TDOC)

Credit Suisse analyst Jailendra Singh maintained a Hold rating on Teladoc today and set a price target of $165.00. The company’s shares closed last Friday at $174.03.

According to TipRanks.com, Singh is a 4-star analyst with an average return of 11.8% and a 78.6% success rate. Singh covers the Services sector, focusing on stocks such as AmerisourceBergen, Cardinal Health, and Owens & Minor.

Teladoc has an analyst consensus of Moderate Buy, with a price target consensus of $173.21, a -1.8% downside from current levels. In a report issued on May 13, SunTrust Robinson also maintained a Hold rating on the stock with a $200.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.